Silencing CD36 gene expression results in the inhibition of latent-TGF-β1 activation and suppression of silica-induced lung fibrosis in the rat

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Wang, Xin ^a   Chen, Ying ^a   Lv, Lina ^a   Chen, Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA1; PEPTIDE FRAGMENT; PRIMER DNA; RNA; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MALE; NONHUMAN; RAT; SILICOSIS; AMINO ACID SEQUENCE; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; EPITHELIUM CELL; GENE VECTOR; GENETICS; LENTIVIRINAE; MINK; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD36; DISEASE MODELS, ANIMAL; DNA PRIMERS; EPITHELIAL CELLS; FEMALE; GENE SILENCING; GENETIC VECTORS; LENTIVIRUS; MALE; MINK; PEPTIDE FRAGMENTS; PULMONARY FIBROSIS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SILICON DIOXIDE; SILICOSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70249119321     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-36     Document Type: Article

References (25)

1. Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A, Metcalfe DD. Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol 2007, 36:43-52. 1899302, 16902192, 10.1165/rcmb.2006-0197OC.
2. Kühlmann UC, Chwieralski CE, Brule S, Röcken C, Reinhold D, Welte T, Bühling F. Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases. Life Sci 2009, 84:1-11. 10.1016/j.lfs.2008.10.001, 18973761.
3. Azuma A, Li YJ, Abe S, Usuki J, Matsuda K, Henmi S, Miyauchi Y, Ueda K, Izawa A, Sone S, Hashimoto S, Kudoh S. Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β1 and thrombospondin. Am J Respir Cell Mol Biol 2005, 32:93-98. 10.1165/rcmb.2003-0374OC, 15557019.
4. Cutroneo KR, White SL, Phan SH, Ehrlich HP. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 2007, 211:585-589. 10.1002/jcp.20972, 17387717.
5. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB. Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin mediated lung fibrosis. J Clin Invest 2004, 114:1308-1316. 524221, 15520863.
6. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg A. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 1993, 92:1812-1818. 288344, 7691887, 10.1172/JCI116771.
7. Chen Y, Chen J, Dong J, Liu W. Antifibrotic effect of Interferon gamma in silicosis model of rat. Toxicol Lett 2005, 155:353-360. 10.1016/j.toxlet.2004.10.011, 15649618.
8. Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, Imai E, Hugo C. Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 2003, 163:1185-1192. 1868256, 12937160.
9. Xu Q, Norman JT, Shrivastav S, Lucio-Cazana J, Kopp JB. In vitro models of TGF-{beta}-induced fibrosis suitable for high-throughput screening of anti-fibrotic agents. Am J Physiol Renal Physiol 2007, 293:F631-640. 10.1152/ajprenal.00379.2006, 17494090.
10. Zhou Y, Koli K, Hagood JS, Miao M, Mavalli M, Rifkin DB, Murphy-Ullrich JE. Latent Transforming Growth Factor-{beta}-binding Protein-4 Regulates Transforming Growth Factor-{beta}1 Bioavailability for Activation by Fibrogenic Lung Fibroblasts in Response to Bleomycin. Am J Pathol 2009, 174:21-33. 10.2353/ajpath.2009.080620, 19056849.
11. Abe M, Oda N, Sato Y, Shibata K, Yamasaki M. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide. Endothelium 2002, 9:25-36. 10.1080/10623320210710, 12901358.
12. Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, Khalil N. Activation of rat alveolar macrophage-derived latent transforming growth factor-β1 by plasmin requires interaction with thrombospondin- 1 and its cell surface receptor, CD36. Am J Pathol 1999, 155:841-851. 1866879, 10487979.
13. Yehualaeshet T, O'Connor R, Begleiter A, Murphy-Ullrich JE, Silverstein R, Khalil N. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol 2000, 23:204-212.
14. van Zoelen EJ, van Oostwaard TM, de Laat SW. PDGF-like growth factor induces EGF-potentiated phenotypic transformation of normal rat kidney cells in the absence of TGF beta. Biochem Biophys Res Commun 1986, 141:1229-1235. 10.1016/S0006-291X(86)80176-0, 3492998.
15. Hemmati AA, Nazari Z, Samei M. A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats. Pulm Pharmacol Ther 2008, 21:668-674. 10.1016/j.pupt.2008.04.004, 18547852.
16. Cutroneo KR. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad3 binding to the proximal promoter of the Smad7 gene. J Cell Biochem 2006, 97:933-939. 10.1002/jcb.20594, 16187293.
17. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D. TGF-β is a critical mediator of acute lung injury. J Clin Invest 2001, 107:1537-1544. 200192, 11413161, 10.1172/JCI11963.
18. Pulichino AM, Wang IM, Caron A, Mortimer J, Auger A, Boie Y, Elias JA, Kartono A, Xu L, Menetski J, Sayegh CE. Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis. Am J Respir Cell Molv Biol 2008, 39:324-336.
19. Venkatesan N, Roughley PJ, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta (1) and interferon gamma. Am J Physiol Lung Cell Mol Physiol 2002, 283:L806-814.
20. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, Gauldie J. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 2001, 163:770-777.
21. Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-β mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1327-1334.
22. Wang Q, Hyde DM, Gotwals PJ, Giri SN. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters. Exp Lung Res 2002, 28:405-417. 10.1080/01902140290096700, 12217209.
23. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989, 170:727-737. 2189427, 2475572, 10.1084/jem.170.3.727.
24. Khalil N, Corne S, Whitman C, Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996, 15:252-259.
25. Gharaee-Kermani M, Ullenbruch M, Phan SH. Animal models of pulmonary fibrosis. Methods Mol Med 2005, 117:251-259.